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ABSTRACT
Model-based control systems are better fitted to glycaemic
control in intensive care than ad-hoc protocols, but de-
pend on predictive accuracy and facilitation of clinical rou-
tines. A general method to customize and visualize model-
based blood glucose predictions is presented. Customiza-
tion is based on admission type and diabetic status of pa-
tients. Blood glucose concentrations of 14 critically ill pa-
tients from two intensive care units were retrospectively
predicted. Relative prediction errors were found to be high-
est for diabetic I and II patients, and lowest for non-diabetic
trauma and head-injured patients. Standard deviations of
mean relative prediction errors are proposed to be used for
display of accuracy of model-based blood glucose predic-
tions in prospectively controlled patients. The method pro-
vides for an optimized timing of blood sampling to facili-
tate tight glucose management in the ICU.
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1 Introduction
Intensive insulin therapy and carbohydrate-reduced meals
are suggested solutions to normalize blood glucose in hy-
perglycaemic intensive care patients [1],[2],[3],[4]. Ad-
hoc sliding scale protocols based on clinical experience
are commonly used to determine the required amount of
insulin. However, no standard protocols or metrics have
been established, which is why blood glucose target ranges
vary between hospitals or even locally between intensive
care wards [5]. Moreover, ad-hoc protocols require a tight
schedule of highly frequent blood glucose measurements
to capture rapidly changing patient conditions [6]. Such
schedules require additional resources, thus increasing the
clinical burden and bear the risk of non-compliance and
failure [7].
Methods based on metabolic models are patient-
specific and provide better control in critical care patients
than ad-hoc protocols [8]. Model-based control methods
enable the prediction of blood glucose outcomes for con-
current glycaemic interventions such as insulin therapy or
nutritional changes. The quality of model-based control
depends highly on prediction accuracy and on how such
methods are able to overcome the need for highly frequent
measuring [9].
This research presents a general method to customize
model predictions to patient subgroups. The customized
predictions are used to display the prediction accuracy over
time in a graphical user interface. The graphical display
enables visual glycaemic control within target ranges self-
defined by a department or hospital. The method provides
for a per-patient based timing of blood glucose measure-
ments to replace fixed high-frequency schedules.
2 Methods
Data from 14 patients from two independent intensive care
units in Aalborg, Denmark and Christchurch, New Zealand
are gathered retrospectively. For this research, the patients
are grouped according to admission type and diabetic sta-
tus. The first group constitutes of five patients from Aal-
borg with either trauma or head-injury and no prior his-
tory of diabetes. The second group is a cross-sectional mix
from Aalborg and Christchurch with two cardiac and three
medical patients, and no prior diabetes. In the third group
are two diabetes I patients from Christchurch, and two di-
abetes II patients from Aalborg and Christchurch. Two in
this group have trauma, one is a general surgical patient,
and one is a medical patient.
Glycaemic control followed local department rules.
Arterial cannula blood samples had been taken. In Aalborg
patients, blood samples were analysed with an ABL700
blood gas analyzer. GlucoCard glucometers were used in
Christchurch. These latter sensors have a larger 7 − 10%
standard error. In both ICUs, insulin was administered
as intravenous infusion of fast-acting insulin, in rare cases
patients received an additional sub-cutaneous bolus injec-
tion. Five of eight Aalborg patients and all patients from
Christchurch were exclusively fed via a feeding tube; three
Aalborg patients received an intermittent intravenous glu-
cose infusion.
Blood glucose concentrations for the three groups are
predicted retrospectively using the Glucosafe model. Glu-
cosafe is a decision-support system based on the metabolic
model derived from Arleth et. al. [10] that adapts dynam-
ically to different patient condition and evolution. Based
on information about past blood glucose measurements, in-
sulin therapy and nutrition, the model determines two pa-
tient specific parameters that are used for model predic-
tions.
Predictions are done by moving forward along the
blood glucose measurements of each patient. At each
measurement, blood glucose concentrations are calculated
over the following 8.5 hours; then the actual measurements
in that time period are paired with their respective pre-
dicted values, and the forward prediction times per mea-
sured/predicted value pair are recorded.
The logarithm of the ratio of measured over predicted
blood glucose concentration gives a relative prediction er-
ror, with a normal distribution and zero mean. Per patient
group,the root mean square (RMS) log relative prediction
error over prediction time interval is calculated from
RMS =
√√√√ 1
n
n∑
i=1
(
ln
mi(t)
pi(t)
)2
(1)
where mi and pi are the ith measured and predicted blood
glucose concentration, respectively, and n is the number of
predictions per interval. Curves are fitted to the RMS log
relative prediction errors of each cohort. Values on each
fitted error curve translate into the standard deviation from
mean relative prediction error and are dependent of patient
group, metabolic model employed, and prediction time.
The standard deviations from mean relative prediction
error yield a range of a maximum and a minimum value
for each predicted blood glucose concentration in prospec-
tively controlled patients. If there is allowance for an error
range of two standard deviations, the range can be calcu-
lated from
2σ(t) = ln
bgmax(t)
bgpred(t)
(2)
−2σ(t) = ln
bgmin(t)
bgpred(t)
(3)
where σ(t) is the standard deviation from mean rel-
ative prediction error, t is the prediction time, bgpred(t)
is the model-predicted blood glucose concentration, and
bgmax(t) and bgmin(t) are the maximum and minimum
blood glucose concentrations.
Model-predicted blood glucose concentrations and
ranges can be displayed on a prediction time axis in
prospectively controlled patients. Intersections with pre-
defined bounds of blood glucose concentrations yield the
time for the next blood glucose measurement.
3 Results
Figure 1 shows the fitted prediction error standard devia-
tions for the three patient groups. Non-diabetic trauma and
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Figure 1. Root mean square (RMS) log relative prediction
error over prediction time. Lines show the fitted prediction
error by cohort: Trauma and head-injured patients (dashed)
had lowest and diabetes I+II patients (dash-dot) had highest
prediction errors. The solid line is the prediction error fit
for a broad cross-section of medical and cardiac patients
without diabetes.
head-injury patients have lowest relative prediction errors,
followed by cardiac and medical patients, and diabetic I+II
patients with highest prediction errors. Both trauma and
diabetic patients show a clear trend towards steadily rising,
saturating curves.
Among patients from Aalborg, mean standard devi-
ations for predictions up to 300 min tend to be lower in
trauma patients (0.133, 0.160, 0.165, 0.173, 0.215) when
compared to cardiac or medical patients (0.208, 0.285) and
the type 2 diabetic trauma patient (0.263) in the group.
Differences are not as pronounced among
Christchurch patients. Mean standard deviations are
high for the two type I diabetic patients (0.287, 0.327)
compared to cardiac and medical patients (0.173, 0.283,
0.303) and one type II diabetic surgical patient (0.178).
APACHE II scores at admission to ICU were avail-
able for the patients from Christchurch. On bivariate 2-
tailed correlation analysis, higher APACHE II scores do not
raise RMS log relative prediction errors.
Figures 2 and 3 show in a proof-of-concept matter
the graphical output of cohort-specific model-based predic-
tions for the cases of a diabetic patient and a trauma patient.
Control limits are arbitrarily set to 3.5–7.5 mmol/L. The
predicted blood glucose concentrations over the following
450 min are displayed with ±2 standard deviations (95%)
error range based on the fitted curves in Figure 1. In the
case of the diabetic patient, the next measurement must oc-
cur after 1 hour (upper intersection) or 2 hours (lower in-
tersection) to avoid going out of the targeted blood glucose
range. For the trauma patient it is sufficient to schedule the
next measurement after 2 hours (upper intersection) or 3
hours (lower intersection).
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Figure 2. Proof-of-concept display of predicted blood glu-
cose with 95% error range for a diabetic patient. Measure-
ments must be scheduled after 1 hour to avoid going out of
the desired blood glucose band. Error range is calculated
from cohort-specific standard deviations in Figure 1.
Thus, cohort specific prediction error can be used with
a desired control tightness (limits) to optimise glucose sam-
ple timing.
4 Discussion
This research presents a general method to customize and
visualize model-based predictions for use in glycaemic
control in intensive care. Customization is based on ad-
mission type and diabetic status. Cohort-specific predic-
tion errors are used to enhance the graphical display of pre-
dicted outcome and accuracy of glycaemic interventions in
prospectively controlled patients. The method makes the
use of fixed blood sample schedules obsolete, because mea-
surement times can be directly read off chart. The timing
of measurements varies, but is depending on the metabolic
model used, cohort specifics, and the blood glucose target
band of the respective intensive care ward.
In this analysis, higher APACHE II scores do not raise
RMS log relative prediction errors. High APACHE score
patients tend to vary more greatly, and glycaemia in pa-
tients with high APACHE II scores may be more difficult
to control [6]. However, APACHE is only a one time as-
sessment after which patients may get better or worse or
both over time. Prediction error is largely a function of the
patients movement over the prediction interval. Thus pre-
diction errors may well not correlate as the APACHE may
no longer be true some time after admission. To get a better
picture of the relationship it takes consecutive assessments
of patient condition and potential variability over several
days. With the data available, no final conclusion on the
influence of APACHE scores can be drawn.
Trauma patients without diabetes had lowest predic-
tion errors. Since all analysed patients received sedatives,
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Figure 3. Graphical output for optimised glucose sampling
in a trauma patient. To stay in the desired range, measure-
ments must be scheduled in 2 hours (upper limit) or 3 hours
(lower limit).
medication alone is not the decisive factor for this observa-
tion. Typically, trauma patients are younger and healthier
and more likely to be getting better without developing sep-
sis, ARDS or pneumonia. Thus, they are likely to vary less
than older, diabetic, already critically ill patients. Another
aspect is that delayed gastric emptying is highly prevalent
(up to 80%) in trauma and head-injury patients [11] and
has a likely effect on the uptake of carbohydrates [12],[13].
This could indirectly be linked to a better predictability of
these patients.
Predictions on diabetes type I and II patients yielded
highest prediction errors, though results may be biased by
the fact that this group contained only four patients with a
highly mixed disease background (two trauma, one surgical
and one medical patient). However, the lack of endogenous
insulin production in type I diabetics is expected to have
unsteadying effects on blood glucose. This is in addition to
the beforehand low insulin sensitivity in these patients, that
enhances small variabilities into bigger changes in blood
glucose for a given intervention.
Differences in blood sample analysis caused differing
measurement errors. This is observed in the extrapolated
intersections with the value axis in Figure 1. Those inter-
sections are assumed to be approximations of mean log rel-
ative measurement error, which are lower for groups with
higher precision at blood sample analysis. Therefore, an
unknown portion of the cohort prediction error differences
is likely to be attributed to measurement error differences.
However, differences are also pronounced within groups
from one ICU, and the physiological particulars in diabet-
ics are likely causes for true differences in prediction errors.
Current results miss the comparison to predictions us-
ing other metabolic models, such as the model developed
by Chase and co-workers in Christchurch [14], to filter
out model-dependent effects on cohort differences. The
results of a comparison of predictive powers of the Glu-
cosafe and the Christchurch model [15] indicate the exis-
tence of model-independent, cohort-specific differences in
glycaemic predictability, though the patients were grouped
by ICU instead of patient characteristics.
5 Conclusion
This method gives clinical staff a convenient graphical
means to base decisions about glycaemic control inter-
vals on the estimated precision of model-based predictions.
The method is generalizable to any model-based glycaemic
control system and any percentage likelihood for the er-
ror bands. The conclusions from cohort-specific analysis
drawn here are based on too small numbers to be definitive,
but merit to be studied more detailed in a larger cohort.
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